Home - Products - Others - Other Targets - β-Glycerophosphate disodium salt hydrate

β-Glycerophosphate disodium salt hydrate

CAS No. 154804-51-0

β-Glycerophosphate disodium salt hydrate ( —— )

Catalog No. M19702 CAS No. 154804-51-0

β-Glycerophosphate is a classical serine-threonine phosphatase inhibitor used in kinase reaction buffers. BGP is often used in combination with other phosphatase/protease inhibitors for broad spectrum inhibition.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 37 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    β-Glycerophosphate disodium salt hydrate
  • Note
    Research use only not for human use.
  • Brief Description
    β-Glycerophosphate is a classical serine-threonine phosphatase inhibitor used in kinase reaction buffers. BGP is often used in combination with other phosphatase/protease inhibitors for broad spectrum inhibition.
  • Description
    β-Glycerophosphate is a classical serine-threonine phosphatase inhibitor used in kinase reaction buffers. BGP is often used in combination with other phosphatase/protease inhibitors for broad spectrum inhibition. It functions as an organic phosphate donor and has been used in culture media for mesenchymal stem cell differentiation to osteoblast-type cells. BGP is also used to buffer M17 media for Lactococcus culture in recombinant protein expression.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    154804-51-0
  • Formula Weight
    234.05
  • Molecular Formula
    C3H9Na2O7P
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    O.[Na+].[Na+].OCC(CO)OP([O-])([O-])=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Ligustrazine hydroch...

    Ligustrazine (hydrochloride) is a natural product.

  • Cinaciguat

    Cinaciguat (BAY 58-2667) is the first of a new class of soluble guanylate cyclase (sGC) activators in clinical development for acute decompensated heart failure.

  • p-Ethoxybenzoic acid

    4-Ethoxybenzoic acid is a compound of luminescent bioapplication.